Strategic Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $788K | Buy |
1,774
+39
| +2% | +$17.3K | 0.08% | 115 |
|
|
2025
Q1 | $841K | Sell |
1,735
-51
| -3% | -$24.7K | 0.09% | 119 |
|
|
2024
Q4 | $719K | Sell |
1,786
-1
| -0.1% | -$403 | 0.08% | 139 |
|
|
2024
Q3 | $831K | Sell |
1,787
-4,005
| -69% | -$1.86M | 0.09% | 129 |
|
|
2024
Q2 | $2.71M | Sell |
5,792
-187
| -3% | -$87.6K | 0.33% | 47 |
|
|
2024
Q1 | $2.5M | Buy |
5,979
+67
| +1% | +$28K | 0.32% | 49 |
|
|
2023
Q4 | $2.41M | Sell |
5,912
-2,752
| -32% | -$1.12M | 0.35% | 50 |
|
|
2023
Q3 | $3.01M | Sell |
8,664
-7,990
| -48% | -$2.78M | 0.5% | 38 |
|
|
2023
Q2 | $5.86M | Buy |
16,654
+7,832
| +89% | +$2.76M | 0.81% | 22 |
|
|
2023
Q1 | $2.78M | Buy |
8,822
+2,912
| +49% | +$917K | 0.5% | 33 |
|
|
2022
Q4 | $1.71M | Buy |
5,910
+924
| +19% | +$267K | 0.35% | 51 |
|
|
2022
Q3 | $1.44M | Buy |
+4,986
| New | +$1.44M | 0.33% | 56 |
|